Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical PracticeDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisActive, not recruitingPhase 42026-07-02NCT06964113

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Eisai Korea Inc.3
Gilead Sciences180

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Eisai Site #1SeoulSouth Korea1
Eisai Site #10SeoulSouth Korea1
Eisai Site #11GyeongnamSouth Korea1
Eisai Site #12SeoulSouth Korea1
Eisai Site #13BusanSouth Korea1
Eisai Site #14SeoulSouth Korea1
Eisai Site #15BusanSouth Korea1
Eisai Site #16Gyeonggi-doSouth Korea1
Eisai Site #17SeoulSouth Korea1
Eisai Site #18JungnamSouth Korea1
Eisai Site #19SeoulSouth Korea1
Eisai Site #2DaejeonSouth Korea1
Eisai Site #3SeoulSouth Korea1
Eisai Site #4Gyeonggi-doSouth Korea1
Eisai Site #5SeoulSouth Korea1
Eisai Site #6DaeguSouth Korea1
Eisai Site #7JungnamSouth Korea1
Eisai Site #8BusanSouth Korea1
Eisai Site #9SeoulSouth Korea1